Cite
Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
MLA
Walker, A. S., et al. “Markers of HIV Infection in the Concorde Trial. Concorde Co-Ordinating Committee.” QJM : Monthly Journal of the Association of Physicians, vol. 91, no. 6, June 1998, pp. 423–38. EBSCOhost, https://doi.org/10.1093/qjmed/91.6.423.
APA
Walker, A. S., Peto, T. E., Babiker, A. G., & Darbyshire, J. H. (1998). Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee. QJM : Monthly Journal of the Association of Physicians, 91(6), 423–438. https://doi.org/10.1093/qjmed/91.6.423
Chicago
Walker, A S, T E Peto, A G Babiker, and J H Darbyshire. 1998. “Markers of HIV Infection in the Concorde Trial. Concorde Co-Ordinating Committee.” QJM : Monthly Journal of the Association of Physicians 91 (6): 423–38. doi:10.1093/qjmed/91.6.423.